Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check26 days agoChange Detected- Footer revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-lapse notice (previous Revision: v3.4.1).SummaryDifference0.4%

- Check61 days agoChange DetectedNotice about government funding and NIH site operations added. The site version updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary toggle option and updated several metadata labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision identifier was updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedA new Revision: v3.3.4 label was added and the previous Revision: v3.3.3 label was removed, indicating a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.